A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

A single dose of psilocybin significantly decreased depression and anxiety in people with cancer, according to a new study. Psilocybin is a chemical in certain mushrooms that causes hallucinogenic ...

A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...

New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in mushrooms-can provide sustained reductions in depression and anxiety in ...

Research shows psilocybin can reduce anxiety for terminal cancer patients, yet federal drug law keeps it out of reach.

The trial tested efficacy outcomes at 2 years for 28 patients enrolled in the phase 2 trial. HealthDay News — For cancer patients with a major depressive disorder, a single dose of psilocybin combined ...

In 1984, my grandfather took his last breath and shuffled off this mortal coil after a nasty bout with cancer. I was only 13 at the time, and probably didn’t fully understand the pain he was in. Not ...

Magic mushrooms might be key to quelling depression among people battling cancer. A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed ...

AURORA, Colo — Researchers at UCHealth are conducting a clinical trial to determine whether psilocybin can ease anxiety and depression in advanced cancer patients. The National Cancer Institute-funded ...

UCLA study finds magic mushrooms can help curb the anxiety of advanced cancer. Sept. 7, 2010— -- When 55-year-old California software developer Pam Sakuda was diagnosed with metastic colon cancer ...

According to a new study, psilocybin, the active ingredient in "magic mushrooms" has a beneficial psychological impact on terminal cancer patients. Researchers in Los Angeles found that the ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy. (HealthDay News) — For cancer patients with a major depressive disorder, a ...